| Summary: | Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V On Medicines With The Active Ingredient Botulinum Toxin Type A (atc Code: M03ax21) |
|
|
|
| Notice Type: | Tender Notice | Deadline: | 26 Jan 2020 |
|
|
|
| Summary: | Open House Drug Discount Agreements Adalimumab Atc L04ab04 |
|
|
|
| Notice Type: | Tender Notice | Deadline: | 06 Nov 2020 |
|
|
|
| Summary: | Open House Drug Discounts Lidocaine Atc N01bb02, Only Dosage Form Plaster |
|
|
|
| Notice Type: | Tender Notice | Deadline: | 06 Nov 2020 |
|
|
|
| Summary: | Conclusion Of Non-exclusive Discount Agreements Pursuant To § 130a Para. 8 Sgb V On Drugs With The Active Substance Prasugrel (atc: B01ac22) Within The Framework Of An Open-house Model. |
|
|
|
| Notice Type: | Tender Notice | Deadline: | 30 Aug 2019 |
|
|
|
| Summary: | Open House Drug Discount Agreements Tapentadol Atc N02ax06 |
|
|
|
| Notice Type: | Tender Notice | Deadline: | 06 Nov 2020 |
|
|
|
| Summary: | Conclusion Of Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V On Finished Medicinal Products Of Different Active Ingredients / Combinations With Possibility Of Termination At Any Ti |
|
|
|
| Notice Type: | Tender Notice | Deadline: | 01 Dec 2020 |
|
|
|
| Summary: | Open House Drug Discount Agreements Lipegfilgrastim Atc L03aa14 |
|
|
|
| Notice Type: | Tender Notice | Deadline: | 06 Nov 2020 |
|
|
|
| Summary: | Purchase Of Kits And Supplies For Nuclear Medicine Ad |
|
|
|
| Notice Type: | Tender Notice | Deadline: | 02 Sep 2019 |
|
|
|
| Summary: | Conclusion Of A Non-exclusive Rebate Agreement Pursuant To § 130a (8) Sgb V On The Active Substance Fosfomycin |
|
|
|
| Notice Type: | Tender Notice | Deadline: | 05 May 2020 |
|
|
|
| Summary: | Conclusion Of A Non-exclusive Rebate Agreement According To § 130a Abs. 8 Sgb V On The Active Substance Enoxaparin, Atc Code: B01ab05 For The Period From 1.4.2018 To Max. As Of 31.3.2020 |
|
|
|
| Notice Type: | Tender Notice | Deadline: | 01 Jan 2020 |
|
|
|
